InvestorsHub Logo
icon url

Whatsupp

04/01/19 3:52 PM

#9399 RE: XenaLives #9397

LOL more BS from Dr Missleading? Sounds like a pump to me.


"The results from the Parkinson's trial could be strong enough for Anavex to gain provisional approval in Australia before the end of the year. "
icon url

InTheTrenches

04/01/19 3:54 PM

#9400 RE: XenaLives #9397

NTRP hands-down leader.

AVXL...not so much.

2-73 for Parkinson's? A graveyard for drug trials. Good luck with that trial. Maybe the placebos are outperforming and asking for extension? Won't know until the trial reads out.

Good luck using a drug (2-73) that is in the same class as drugs (S1R) that have failed in placebo-controlled Alzheimer's trials.